Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Community Mental Health Journal|January 30, 2020
Medications for Opioid Use Disorder Utilization Among Oxford House ResidentsJohn M Majer, Leonard A Jason, Joshua Norris, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|September 5, 2015
PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice by inhibiting ghrelin and increasing GLP-1 and leptinJohn P Vu, Deepinder Goyal, Leon Luong, et al.Journal of Molecular Neuroscience : MN|January 8, 2014
Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in miceJohn P Vu, Mulugeta Million, Muriel Larauche, et al.Journal of Molecular Neuroscience : MN|April 24, 2015
Regulation of Appetite, Body Composition, and Metabolic Hormones by Vasoactive Intestinal Polypeptide (VIP)John P Vu, Muriel Larauche, Martin Flores, et al.Community Mental Health Journal|March 26, 2018
Correction to: Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow ResidentsJohn M Majer, Christopher Beasley, Emily Stecker, et al.Community Mental Health Journal|January 6, 2018
Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow ResidentsJohn M Majer, Christopher Beasley, Emily Stecker, et al.Pageof 1